Adverse Event Reporting
| VAERS ID | 1989462 |
|---|---|
| Gender | Female |
| Age | 82 |
| StateCode | MT |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | EN5318 |
| Number of vaccinations | 2 |
| Vaccinated | 2021-01-30 |
| Onset | 2021-09-25 |
| Condition | Hospitalized Died |
Symptoms
- Intensive care
- Respiratory arrest
- SARS-CoV-2 test positive
- COVID-19
- Acute myocardial infarction
- Delirium
- Death
- Lung opacity
- Pulmonary oedema
- Acute respiratory failure
- Percutaneous coronary intervention
- Renal failure
- SARS-CoV-2 RNA
- Positive airway pressure therapy
Current Illness
? CAD (coronary artery disease) LAD stent 2000; LM & LAD stents 1/2017; 2 stents RCA 3/2017 ? Hyperlipidemia ? Hypertension Resistant HTN; neg OSA screen, normal renal artery US ? Localized osteoarthritis of shoulder, right ? SIADH (syndrome of inappropriate ADH production) (HCC) Hosp 2/2017 with hyponatremia w/ Na 112; HCTZ was d/c'd
Preexisting Conditions
? CAD (coronary artery disease) LAD stent 2000; LM & LAD stents 1/2017; 2 stents RCA 3/2017 ? Hyperlipidemia ? Hypertension Resistant HTN; neg OSA screen, normal renal artery US ? Localized osteoarthritis of shoulder, right ? SIADH (syndrome of inappropriate ADH production) (HCC) Hosp 2/2017 with hyponatremia w/ Na 112; HCTZ was d/c'd
Other Medications
L-Lysine Luloxetine Garlic Omperazole, Sprionolactone Losartan Nitroglycerine (PRN) Vitimin C Aspirin 81 mg Albuterol inhaler PRN Amlodipine Calcium carbonate Cholecalciferol Atenolol Atorvastatin
Previous Vaccinations
Allergies
? Brilinta [Ticagrelor] Other (See Comments) Recurrent epistaxis requiring multiple interventions with ENT while on Brilinta + aspirin ? Carvedilol Other (See Comments) Constipation and headache ? Cephalexin Monohydrate "Pretty good hives" from 2003, confirmed w/ Savmor ? Codeine Sulfate ? Oxycodone Hcl ? Penicillins Hives ? Sulfanilamide Sulfanilamide, Sulfanilamide
Laboratory Data
Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe Ordered Test Codes: 94500-6 (LN LOINC)/ Status: Final Accession Number: 212680041LP-198922 Specimen Source: SOFT TISSUE SAMPLE Specimen Site: ENTIRE NASOPHARYNX(181200003) Specimen Collection Date/Time: 2021-09-25 17:11:00.
0 Results: * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: DETECTED Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2021-09-25 18:31:46.
0 Interpretation: Very abnormal Result Method: LAB DEVICE: CEPHEID GENEXPERT DX SYSTEM (7332940001377) Status: Final Result Comments: Critical value(s) called with read back verification.
Write-up
Case completed primary Pfizer series in January 2021, then died of Covid September 2021.
At Hospital, discharging physician MD.
From some combination of pulmonary edema from non-ST elevation MI, Covid infection, moderate patchy bilateral airspace opacities -Required BiPAP on arrival to the ICU on the 25th -Decompensation with respiratory arrest, potentially associated with olanzapine IV, severe delirium on the 27th Continue BiPAP Hospital Course: Patient was admitted about 48 hours ago with STEMI requiring coronary PCI.
Unfortunately she had a respiratory arrest and went into renal failure.
The family was consulted with the poor prognosis and the need for dialysis and potentially long-term ventilation care.
They opted instead for comfort measures later this afternoon.
She was placed on comfort care measures and passed away at 2055